Innovation since inception

At Zumutor, we make the good better. Our goal is to use next generation antibody technologies to make new biological entities. Our focus is on disease areas that are today’s concerns, mainly in the segments of Oncology. Our interest also lies in Diabetes and Autoimmune Disorders. Our commitment is to create portfolio value for partners, both regional and across the world with biologics that meet international quality standards.

What We Do

We develop therapeutics encompassing recombinant technology-based biosimilars to large antibody structures – the mAbs

We create product portfolios focused on immuno-oncology

We develop new drugs with breakaway potential that will foray into a new realm of improved biologics

Zumutor’s best-in-class labs, combined with state of the art technologies, enable the development of better biologics.

Clients can also avail cell line development, analytical method development and testing, protein characterization, process development, process characterization/scale down validation, and technology transfer services.